Emetogenicity of Chemotherapies

Reference work entry


Chemotherapies can be classified according to their emetogenic potential in: highly emetogenic chemotherapies (almost all patients not receiving antiemetic prophylaxis suffer from CINV; i.e., cisplatin, dacarbazine); moderately emetogenic chemotherapies (many, but not all, patients suffer from CINV if not treated; i.e., cyclophosphamide- and anthracycline-containing chemotherapies); chemotherapies with a low emetogenic potential (only a very few patients who do not receive antiemetic prophylaxis experience CINV).


Public Health Social Policy Emetogenic Chemotherapy Antiemetic Prophylaxis Emetogenic Potential 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media LLC 2010

Personalised recommendations